Peer Navigation for HIV Prevention
(MATCH Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help Black women in Baltimore start using PrEP, a medication that can prevent HIV. It will explore how a support system, including group and one-on-one sessions with a peer navigator, can facilitate and sustain PrEP initiation. Participants will either join a Peer Navigation Group with regular peer navigator meetings or a control group with just one session. Women who identify as Black, have not taken PrEP before, and have had unprotected sex with at least one male partner in the past six months might be suitable candidates. As an unphased trial, this study offers participants the opportunity to contribute to important research that could improve access to HIV prevention methods for Black women.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the Peer Navigation Group is safe for participants?
Research shows that peer navigation is well-received and can help prevent HIV. Studies have found that peer navigators improve HIV care and prevention for many people, including those facing stigma and discrimination. These studies generally reported positive results without major safety concerns. Peer navigation involves trained individuals who guide and support participants. This approach is safe because it does not involve new drugs or medical procedures, making it a low-risk option for those considering joining such a trial.12345
Why are researchers excited about this trial?
Researchers are excited about the Peer Navigation Group for HIV prevention because it offers a more personalized and supportive approach compared to standard methods like medication adherence programs or counseling. This method involves participants engaging in multiple sessions, both in groups and one-on-one, with a peer navigator who has personal experience with HIV prevention. The unique feature here is the peer-led support, which can foster trust and relatability, potentially leading to better engagement and outcomes. This approach could empower individuals in a way traditional treatments might not, by providing direct support from someone who has navigated similar experiences.
What evidence suggests that the Peer Navigation Group is effective for increasing PrEP initiation among Black women?
This trial will compare the effectiveness of peer navigation with a control group for HIV prevention. Studies have shown that peer navigation can significantly enhance HIV prevention and care. Trained individuals with similar experiences assist others in navigating the health care system. Research indicates that peer navigation has maintained low virus levels and improved access to care. Additionally, when combined with pre-exposure prophylaxis (PrEP), peer navigation has effectively boosted HIV prevention efforts. This approach shows promise for supporting groups facing unique challenges, such as intimate partner violence and discrimination, making it a hopeful strategy for increasing PrEP use among Black women.23678
Who Is on the Research Team?
Tiara C. Willie, PhD, MA
Principal Investigator
Johns Hopkins Bloomberg School of Public Health
Are You a Good Fit for This Trial?
This trial is for Black women at high risk of HIV, focusing on those who have faced intimate partner violence and gendered racism. It aims to help them start using pre-exposure prophylaxis (PrEP) for HIV prevention.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive 4 weekly group sessions and 4 one-on-one sessions with a peer navigator
Control
Participants receive a single group session
Follow-up
Participants are monitored for PrEP initiation and adherence
What Are the Treatments Tested in This Trial?
Interventions
- Peer Navigation Group
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins Bloomberg School of Public Health
Lead Sponsor
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator